|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li LL, Xue AM, Li BX, Shen YW, Li YH, Luo
CL, Zhang MC, Jiang JQ, Xu ZD, Xie JH and Zhao ZQ: JMJD2A
contributes to breast cancer progression through transcriptional
repression of the tumor suppressor ARHI. Breast Cancer Res.
16:R562014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng W, Lu Z, Luo RZ, Zhang X, Seto E,
Liao WS and Yu Y: Multiple histone deacetylases repress tumor
suppressor gene ARHI in breast cancer. Int J Cancer. 120:1664–1668.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Travis RC and Key TJ: Oestrogen exposure
and breast cancer risk. Breast Cancer Res. 5:239–247. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li L, Gao P, Li Y, Shen Y, Xie J, Sun D,
Xue A, Zhao Z, Xu Z, Zhang M, et al: JMJD2A-dependent silencing of
Sp1 in advanced breast cancer promotes metastasis by downregulation
of DIRAS3. Breast Cancer Res Treat. 147:487–500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang H, Stephens LC and Kumar R:
Metastasis tumor antigen family proteins during breast cancer
progression and metastasis in a reliable mouse model for human
breast cancer. Clin Cancer Res. 12:1479–1486. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Hoon M, Shin JW and Carninci P:
Paradigm shifts in genomics through the FANTOM projects. Mamm
Genome. 26:391–402. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pennisi E: Genomics. ENCODE project writes
eulogy for junk DNA. Science. 337:1159–1161. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Wang W, Cao L, Li Z and Wang X:
Long non-coding RNA CCAT1 acts as a competing endogenous RNA to
regulate cell growth and differentiation in acute myeloid leukemia.
Mol Cells. 39:330–336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo X and Hua Y: CCAT1: An oncogenic long
noncoding RNA in human cancers. J Cancer Res Clin Oncol.
143:555–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun M, Gadad SS, Kim DS and Kraus WL:
Discovery, annotation, and functional analysis of long noncoding
RNAs controlling cell-cycle gene expression and proliferation in
breast cancer cells. Mol Cell. 59:698–711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A cytoplasmic NF-κB interacting
long noncoding RNA blocks IκB phosphorylation and suppresses breast
cancer metastasis. Cancer Cell. 27:370–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Su JC and Hu XF: Long non-coding RNA
HOXA11-AS promotes cell proliferation and metastasis in human
breast cancer. Mol Med Rep. 16:4887–4894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Yang J, Qian L and Cao T:
Aberrantly expressed mRNAs and long non-coding RNAs in patients
with invasive ductal breast carcinoma: A pilot study. Mol Med Rep.
11:2185–2190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang R, Wu JC, Zheng LM, Li ZR, Zhou KL,
Zhang ZS, Xu DF and Chen C: Long noncoding RNA RUSC1-AS-N indicates
poor prognosis and increases cell viability in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 22:388–396. 2018.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Banas T, Juszczyk G, Pitynski K,
Nieweglowska D, Ludwin A and Czerw A: Incidence and mortality rates
in breast, corpus uteri, and ovarian cancers in Poland (1980–2013):
An analysis of population-based data in relation to socioeconomic
changes. Onco Targets Ther. 9:5521–5530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meissner HI, Klabunde CN, Han PK, Benard
VB and Breen N: Breast cancer screening beliefs, recommendations
and practices: Primary care physicians in the United States.
Cancer. 117:3101–3111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee EY and Muller WJ: Oncogenes and tumor
suppressor genes. Cold Spring Harb Perspect Biol. 2:a0032362010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun H, Wang G, Peng Y, Zeng Y, Zhu QN, Li
TL, Cai JQ, Zhou HH and Zhu YS: H19 lncRNA mediates
17β-estradiol-induced cell proliferation in MCF-7 breast cancer
cells. Oncol Rep. 33:3045–3052. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arase M, Horiguchi K, Ehata S, Morikawa M,
Tsutsumi S, Aburatani H, Miyazono K and Koinuma D: Transforming
growth factor-β-induced lncRNA-Smad7 inhibits apoptosis of mouse
breast cancer JygMC(A) cells. Cancer Sci. 105:974–982. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li
J, Guo Q, Gong C, Liu B and Su S: NBAT1 suppresses breast cancer
metastasis by regulating DKK1 via PRC2. Oncotarget. 6:32410–32425.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu Y, Ginther C, Kim J, Mosher N, Chung S,
Slamon D and Vadgama JV: Expression of Wnt3 activates Wnt/β-catenin
pathway and promotes EMT-like phenotype in trastuzumab-resistant
HER2-overexpressing breast cancer cells. Mol Cancer Res.
10:1597–1606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Z, Lu P, Zhang H, Xu H, Gao N, Li M
and Liu C: Nestin positively regulates the Wnt/β-catenin pathway
and the proliferation, survival and invasiveness of breast cancer
stem cells. Breast Cancer Res. 16:4082014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Z and Xie L: LHX6 inhibits breast
cancer cell proliferation and invasion via repression of the
Wnt/β-catenin signaling pathway. Mol Med Rep. 12:4634–4639. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Proffitt KD, Madan B, Ke Z, Pendharkar V,
Ding L, Lee MA, Hannoush RN and Virshup DM: Pharmacological
inhibition of the Wnt acyltransferase PORCN prevents growth of
WNT-driven mammary cancer. Cancer Res. 73:502–507. 2013. View Article : Google Scholar : PubMed/NCBI
|
